Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Oregon team zeroes in on RNA-binding in myotonic dystrophy

09.11.2007
Study helps to determine normal functioning, giving clues to how disease state happens

University of Oregon researchers have shed new light on the function of an RNA-regulating protein known as muscleblind, which when it misbehaves and binds to rogue RNA can lead to disease affecting roughly one in 8,000 people.

The study, which used a combination of biochemical, biophysical and cell culture studies, was placed online ahead of regular publication in the December issue of the journal RNA. When the findings were initially presented in September at the annual meeting of the Myotonic Dystrophy Foundation in Italy, the work garnered a $1,000 cash prize for outstanding research for lead author Bryan Warf, a UO doctoral student.

Misbehaving RNA can lead to myotonic dystrophy, an inherited condition that affects muscles and other body systems. It is the most commonly occurring form of adult onset muscular dystrophy with progressive muscle wasting as well as a variety of symptoms. An early symptom is the inability of muscles to relax after a simple handshake or gripping of a doorknob. It also can lead to cataracts, cardiac arrhythmia, insulin resistance and male infertility. It can be life-threatening in cases of early onset, particularly in children. Researchers believe that the numbers of a specific type of nucleotide expansions in a person's DNA gives rise to myotonic dystrophy.

... more about:
»MBNL »RNA »dystrophy »myotonic »structure »toxic

The UO findings apply to both known forms: DM1, which can manifest at any point in life, from birth to late 60s; and DM2, which more commonly surfaces in adulthood. While independent genes are responsible in each form, the same protein's interaction with RNA in the genes is implicated in both diseases.

"In a simplistic view, this disease is about this protein not functioning properly," Warf said. "So we've been trying to see what this protein does normally to keep us healthy and promote healthy development."

In their study, Warf and Andy Berglund, professor of chemistry and member of the Institute of Molecular Biology, focused on the RNA-splicing protein muscleblind-like (MBNL) and its interactions with both normal strands of RNA and disease-causing RNA that contains mismatched pairs of repeat nucleotides. RNA (ribonucleic acid) is much like translation software, a driver that serves as a messenger between DNA and proteins.

"Toxic RNA," as Berglund describes the mutated strands in the genome, is like a sentence that contains many extra misplaced copies of the word "the" within it. In their paper, Warf and Berglund found that MBNL binds to both normal and toxic forms of RNA. When bound to the toxic versions, MBNL ignores its other RNA targets and does not help process them normally, leading to disease. In earlier work, Berglund's lab solved the crystal structure of the toxic RNA.

In this new study, Warf and Berglund tested MBNL's interactions with both normal RNA and toxic RNA. They found that muscleblind has no preference for a toxic RNA that contains any type of pyrimidine-pyrimidine mismatch. Warf and Berglund were the first to articulate the structure of one of MBNL’s normal RNA targets. It had been thought that the structure of the toxic RNA was much different than the structure of a normal RNA target for MBNL, but Warf and Berglund showed that the two structures are actually quite similar.

"Through his studies," Berglund said, "Bryan has provided insight into how muscleblind may normally function. The dogma was that this protein was recognizing a complex structure in the toxic RNA, and normally it was recognizing a more simple RNA structure in regulating splicing. Bryan found the RNA that is normally recognized actually adopts a structure that looks a lot like the toxic RNA. Muscleblind recognizes both. The diseased RNA is mimicking the natural RNA."

Jim Barlow | EurekAlert!
Further information:
http://www.uoregon.edu

Further reports about: MBNL RNA dystrophy myotonic structure toxic

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>